{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:40:04Z","timestamp":1791283204961,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.medcli.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T12:22:46Z","timestamp":1566303766000},"page":"360-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoanticuerpos en neuropat\u00edas inflamatorias inmunomediadas"],"prefix":"10.1016","volume":"153","author":[{"given":"Lorena","family":"Mart\u00edn-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Pascual-Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.06.007_bib0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0310","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0315","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Man","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0320","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0325","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0330","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in 2patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: A systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0340","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0345","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1529-8027.2012.00407.x","article-title":"Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies","volume":"17","author":"Rojas-Garc\u00eda","year":"2012","journal-title":"J Peripher Nerv Syst."},{"key":"10.1016\/j.medcli.2019.06.007_bib0350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11940-010-0103-8","article-title":"Fisher syndrome","volume":"13","author":"Mori","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.medcli.2019.06.007_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.05.020","article-title":"Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome)","volume":"215","author":"Yuki","year":"2009","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(98)00016-2","article-title":"Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barr\u00e9 syndrome?","volume":"86","author":"Koga","year":"1998","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0365","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI113231","article-title":"Activation of terminal components of complement in patients with Guillain-Barre syndrome and other demyelinating neuropathies","volume":"80","author":"Koski","year":"1987","journal-title":"J Clin Invest."},{"key":"10.1016\/j.medcli.2019.06.007_bib0370","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: An antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","article-title":"Nodes, paranodes and neuropathies","volume":"89","author":"Fehmi","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2019.06.007_bib0380","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis."},{"issue":"10026","key":"10.1016\/j.medcli.2019.06.007_bib0385","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(16)30058-7","article-title":"Guillain-Barr\u00e9 syndrome associated with Zika virus infection","volume":"387","author":"Brasil","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2019.06.007_bib0390","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barre syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"Van den Berg","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0395","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology."},{"issue":"Pt 5","key":"10.1016\/j.medcli.2019.06.007_bib0400","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/122.5.807","article-title":"Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro","volume":"122","author":"Paparounas","year":"1999","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0405","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0410","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: Implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0415","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0420","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2019.06.007_bib0425","first-page":"22","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0430","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol NeuroInflammation."},{"key":"10.1016\/j.medcli.2019.06.007_bib0435","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0440","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0445","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.medcli.2019.06.007_bib0455","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0460","first-page":"1","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"1","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.medcli.2019.06.007_bib0465","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.medcli.2019.06.007_bib0470","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cNeuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2019.06.007_bib0475","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic Inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: An anti-paranode and podocyte protein antibody study and literature survey","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0480","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0485","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/brain\/awy134","article-title":"Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: An ultrastructural study","volume":"141","author":"Vallat","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/awg030","article-title":"Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies","volume":"126","author":"Kwa","year":"2003","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0495","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","article-title":"Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Querol","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.medcli.2019.06.007_bib0500","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jnnp-2013-305755","article-title":"Sensitivity and predictive value of anti-GM1\/galactocerebroside IgM antibodies in multifocal motor neuropathy","volume":"85","author":"Nobile-Orazio","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.medcli.2019.06.007_bib0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2014first revision","volume":"15","year":"2010","journal-title":"J Peripher Nerv Syst."},{"key":"10.1016\/j.medcli.2019.06.007_bib0510","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2014.11.001","article-title":"Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays","volume":"278","author":"Delmont","year":"2015","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.24680","article-title":"Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model","volume":"80","author":"Harschnitz","year":"2016","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0520","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1212\/NXI.0000000000000119","article-title":"Complement activity is associated with disease severity in multifocal motor neuropathy","volume":"2","author":"Vlam","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.medcli.2019.06.007_bib0525","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2011.00328.x","article-title":"An open label clinical trial of complement inhibition in multifocal motor neuropathy","volume":"16","author":"Fitzpatrick","year":"2011","journal-title":"J Peripher Nerv Syst."},{"key":"10.1016\/j.medcli.2019.06.007_bib0530","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.58.4.615","article-title":"Axonal multifocal motor neuropathy without conduction block or other features of demyelination","volume":"58","author":"Katz","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0535","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/mus.24326","article-title":"The clinical spectrum of isolated peripheral motor dysfunction","volume":"51","author":"Sanderson","year":"2015","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2019.06.007_bib0540","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1468-1331.2006.01142.x","article-title":"Prediction of response to IVIg treatment in patients with lower motor neurone disorders","volume":"13","author":"Strigl-Pill","year":"2006","journal-title":"Eur J Neurol."},{"issue":"Pt 5","key":"10.1016\/j.medcli.2019.06.007_bib0545","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/117.5.941","article-title":"Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside","volume":"117","author":"Kaku","year":"1994","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0550","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","article-title":"Polyneuropathy with anti-sulfatide and anti-MAG antibodies: Clinical, neurophysiological, pathological features and response to treatment","volume":"281","author":"Campagnolo","year":"2015","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0560","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0565","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/NEN.0b013e3181fa44af","article-title":"Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy","volume":"69","author":"Kawagashira","year":"2010","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0570","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410330514","article-title":"Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein","volume":"33","author":"Tatum","year":"1993","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0575","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","article-title":"A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy","volume":"249","author":"Comi","year":"2002","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2019.06.007_bib0580","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"Leger","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0585","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000265055.28218.cc","article-title":"Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy","volume":"69","author":"Niermeijer","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.06.007_bib0590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jnnp.2009.183517","article-title":"Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(\u03b12-3)Gal","volume":"81","author":"Rojas-Garcia","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.medcli.2019.06.007_bib0595","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.06.007_bib0600","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319304488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319304488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T09:21:37Z","timestamp":1572340897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775319304488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0025775319304488"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.06.007","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoanticuerpos en neuropat\u00edas inflamatorias inmunomediadas","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}